Abstract
The drug discovery and development process is advancing with time and in-silico research has enabled the identification of new drugs through target identification and validation. In-silico screening, quantitative structure-activity relationship, and quantitative structure–property relationship models are some techniques used to evaluate potential compounds with drug-like properties. The process of discovering new drugs is a time-consuming process spanning many years of hard work and resources. This chapter is an introductory chapter that provides information on recent trends in drug discovery in the post-genomic era. It discusses drug-discovery approaches using computational methods for target identification, validation, and homology modeling.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Phytochemistry, Computational Tools, and Databases in Drug Discovery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
